Document:

<PAGE>   1
                                                                    EXHIBIT 10.9

                                 AMENDMENT NO. 4

                            DATED AS OF MARCH 8, 2000

                                       TO

                      SECOND AMENDED AND RESTATED REVOLVING
                           LOAN AND SECURITY AGREEMENT

                          DATED AS OF NOVEMBER 21, 1997

                                      AMONG

                             HEALTHGRADES.COM, INC.
                      FORMERLY SPECIALTY CARE NETWORK, INC.

                            HEALTHCARE RATINGS, INC.,

                              PROVIDERWEB.NET, INC.

                                       AND

                             BANK OF AMERICA, N.A.,
                                  AMSOUTH BANK,
                                    PARIBAS,
                           KEY CORPORATE CAPITAL, INC.

                                       AND

                         BANK OF AMERICA, N.A., AS AGENT

<PAGE>   2

                                TABLE OF CONTENTS

<TABLE>

<S>                                                                         <C>
1.       Definitions..........................................................2

2.       Amendments to Agreement..............................................2

3.       Representations and Warranties.......................................4
         3.1      Incorporation...............................................4
         3.2      Due Authorization, No Conflicts, Etc........................5
         3.3      Due Execution, Etc..........................................5

4.       Conditions Precedent.................................................6
         4.1      Conditions Precedent to Effectiveness of Amendment No. 4....6

5.       Effectiveness of Amendment No. 4.....................................8

6.       Closing..............................................................8

7.       Governing Law, Etc...................................................8

8.       Section Titles and Table of Contents.................................9

9.       Arbitration..........................................................9

10.      Counterparts........................................................10

11.      Agreement to Remain in Effect.......................................10
</TABLE>

                                      -ii-
<PAGE>   3

         This Amendment No. 4 to Second Amended and Restated Revolving Loan and
Security Agreement, made and entered into as of this 8th day of March, 2000, by
and among Healthgrades.com, Inc. (formerly Specialty Care Network, Inc.) (the
"Borrower"); the Guarantors, jointly and severally; the various banks and
lending institutions on the signature pages attached hereto together with all
assignees of such banks and lending institutions (each a "Bank" and collectively
the "Banks"); and Bank of America, N.A., successor to NationsBank, N.A.,
successor to NationsBank of Tennessee, N.A., as agent (the "Agent").

                              W I T N E S S E T H:

         WHEREAS, the Borrower, the Guarantors, the Banks, the Swingline Bank,
and the Agent entered into a certain Second Amended and Restated Revolving Loan
and Security Agreement dated as of November 21, 1997, as amended by Amendment
No. 1 thereto dated March 30, 1998, Amendment No. 2 thereto dated April 1, 1998,
and Amendment No. 3 thereto dated September 16, 1999 (collectively the "Loan
Agreement"); and

         WHEREAS, Healthcare Report Cards, Inc. and SCN of Princeton, Inc., both
formerly Guarantors, have each been dissolved; and

         WHEREAS, at the time of its dissolution, Healthcare Report Cards, Inc.
owned ninety percent (90%) of the outstanding shares of HG.com, Inc., which
entity has been merged into Healthcare Ratings, Inc., a newly formed Subsidiary
of the Borrower; and

         WHEREAS, the Borrower has also formed as a new Subsidiary
Providerweb.net, Inc.; and

         WHEREAS, the parties to the Loan Agreement desire to amend the existing
Loan Agreement to delete Healthcare Report Cards, Inc. and SCN of Princeton,
Inc. as Guarantors thereunder, to add Healthcare Ratings, Inc., a Delaware
corporation, and Providerweb.net, Inc., a

                                     - 1 -
<PAGE>   4

Delaware corporation, as Guarantors, to pledge additional Collateral including
without limitation all outstanding shares issued by Healthcare Ratings, Inc. and
Providerweb.net, Inc. to the Borrower, and to modify certain covenants, all as
hereinafter more specifically set forth;

         NOW THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements set forth herein, and for other good and valuable
consideration, the receipt and legal sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:

         1. DEFINITIONS. All capitalized terms used in this Amendment No. 4
which are not otherwise defined herein shall have the respective meanings
ascribed thereto in the Agreement.

         2. AMENDMENTS TO AGREEMENT.

         2.1 In the Exhibits to the Agreement, EXHIBIT A, being the "Form of
Notes", is hereby modified to the extent set forth in the Modification to Term
Loan Note attached hereto as EXHIBIT 1.

         2.2 Section I of the Agreement, DEFINITIONS, is hereby amended by
adding thereto the following new definitions as follows:

                  "AMENDMENT NO. 4 EFFECTIVE DATE" has the meaning specified in
         Section 5 of Amendment No. 4.

         In addition to the foregoing new definitions, the following definitions
are hereby amended: "COMMITTED AMOUNT" is hereby amended to equal that amount
set forth opposite each Bank's signature hereto, which amount is for a Term Loan
only; "GUARANTOR" is hereby amended to add Healthcare Ratings, Inc. and
Providerweb.net, Inc. as Guarantors; and "TOTAL COMMITMENTS" is hereby amended
to replace the figure of Twelve Million Five Hundred Thousand and No/100 Dollars
($12,500,000.00) with the figure Eight Million One Hundred Thousand and No/100
Dollars ($8,100,000.00) in non-revolving Term Loans.

                                     - 2 -
<PAGE>   5

         2.3 Paragraph 2.1 is hereby amended to delete that portion of the
second sentence beginning with "provided" and to insert thereafter the
following:

         provided, immediately upon receipt but in any event before July 1,
         2000, the Borrower shall also apply as a principal prepayment on the
         Notes the full amount of Borrower's federal tax refund for 1999, said
         prepayment to be applied in inverse order of maturity.

         2.4 Healthcare Ratings, Inc. and Providerweb.net, Inc. hereby agree to
become parties to the Loan Agreement and each hereby grants to the Agent on
behalf of the Banks a security interest in the Collateral, including without
limitation the grant of the security interest described in Section 4.3 of the
Loan Agreement, and confirms that, as more specifically set forth in Section 4.4
thereof, said liens are first and prior liens.

         2.5 Borrower hereby covenants with the Banks that, at all times during
the term hereof, it shall maintain cumulative cash deposits with any one or more
of the Banks of no less than the lesser of: (i) Five Million and No/100 Dollars
($5,000,000.00), or (ii) 100% of the outstanding Obligations from time to time,
which cash shall be used at maturity to pay off the Term Loans and all other
Obligations. The Banks hereby covenant with the Borrower that the Banks shall
not exercise any right of setoff against said deposits unless and until there is
a payment default by the Borrower with respect to principal and/or interest on
the Obligations, including without limitation Borrower's failure to pay
principal and interest after an acceleration of the Obligations.

         2.6 Subparagraph 6.2(H) is hereby deleted in its entirety and replaced
with a new subparagraph 6.2(H) as follows:

         (H) On the 15th and 30th of each month, a bimonthly report setting
         forth the following information: (a) the amount and location of cash
         deposits held by Borrower with each of the Banks, and (b) the status of
         any payments to be received by Borrower from each its managed

                                     - 3 -
<PAGE>   6

         Practices, including without limitation The Specialist, MAOS, Orlin &
         Cohen, Lima, SEN, and the like.

         2.7 As consideration for the Banks agreeing to this Amendment No. 4,
the Borrower has herewith delivered to the Banks as a non-refundable fee 165,000
shares of common stock of the Borrower, as follows: 66,000 shares issued to Bank
of America, N.A. or its designee; 33,000 shares issued to AmSouth Bank or its
designee; 33,000 shares issued to Key Corporate Capital, Inc. or its designee;
and 33,000 shares issued to Paribas or its designee. This stock is issued
pursuant to the provisions of TCA '47-24-101, and is intended as an "equity
participation" in Borrower and not as interest on the Obligations. In addition,
the Borrower agrees to enter into a registration rights agreement with each of
the Banks (or their respective designees) with respect to such stock granting to
the Banks (or their designee) piggyback registration rights.

         3. REPRESENTATIONS AND WARRANTIES. To induce the Banks and the Agent to
enter into this Amendment No. 4, the Borrower and Guarantors jointly and
severally represent and warrant to the Banks and the Agent as follows:

         3.1 INCORPORATION. Healthgrades.com, Inc. is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Delaware; has the corporate power to own its properties and to engage in the
business it conducts, and is duly qualified and in good standing as a foreign
corporation in the jurisdictions wherein the nature of its business or the
ownership of its properties requires it to be so qualified. Healthcare Ratings,
Inc. is a corporation duly organized, validly existing and in good standing
under the laws of the State of Delaware; has the corporate power to own its
properties and to engage in the business it conducts, and is duly qualified and
in good standing as a foreign corporation in the jurisdictions wherein the
nature of its business or the ownership of its properties requires it to be so
qualified. Providerweb.net, Inc. is

                                     - 4 -
<PAGE>   7

a corporation duly organized, validly existing and in good standing under the
laws of the State of Delaware; has the corporate power to own its properties and
to engage in the business it conducts, and is duly qualified and in good
standing as a foreign corporation in the jurisdictions wherein the nature of its
business or the ownership of its properties requires it to be so qualified.

         3.2 DUE AUTHORIZATION, NO CONFLICTS, ETC. The execution, delivery and
performance by the Borrower and Guarantors of this Amendment No. 4 and any and
all other agreements, instruments and documents to be executed and/or delivered
by the Borrower and Guarantors pursuant hereto or in connection herewith, and
the consummation by the Borrower and Guarantors of the transactions contemplated
hereby or thereby: (a) are within their respective corporate powers; (b) have
been duly authorized by all necessary corporate action, including without
limitation, the consent of stockholders where required; (c) do not and will not
conflict with or result in any breach of, or constitute with the passage of time
or the giving of notice or both, a default under (i) any Requirement of Law or
(ii) any agreement to which Borrower or any Guarantor is a party or by which
they, or any of their respective property, is bound; and (d) do not require the
consent, authorization by, or approval of, or notice to, or filing or
registration with, any governmental authority or any other Person other than
those which have been obtained and copies of which have been delivered to the
Agent pursuant to Subsection 4.1(a)(ii) hereof, each of which is in full force
and effect.

         3.3 DUE EXECUTION, ETC. This Amendment No. 4 and each of the other
agreements, instruments and documents to be executed and/or delivered by the
Borrower or any Guarantor pursuant hereto or in connection herewith (a) has been
duly executed and delivered, and (b) constitutes the legal, valid and binding
obligation of the Borrower and each Guarantor, enforceable

                                     - 5 -
<PAGE>   8

against it in accordance with its terms, subject however to state and federal
bankruptcy, insolvency, reorganization and other laws and general principles of
equity affecting enforcement of the rights of creditors generally.

         4. CONDITIONS PRECEDENT. The effectiveness of this Amendment No. 4 is
subject to the fulfillment of the following conditions precedent on or prior to
the Amendment No. 4 Effective Date (as hereinafter defined in Section 5 hereof):

         4.1 CONDITIONS PRECEDENT TO EFFECTIVENESS OF AMENDMENT NO. 4. The Agent
shall have received, on or prior to the Amendment No. 4 Effective Date, the
following, each dated on or prior to the Amendment No. 4 Effective Date unless
otherwise indicated, in form and substance satisfactory to the Agent and in
sufficient copies for each Bank:

             (a) Certified copies of (i) the resolutions of the Board of
Directors of the Borrower and each Guarantor approving this Amendment No. 4 and
each other agreement, instrument or document to be executed by it pursuant
hereto or as contemplated hereby, and (ii) all documents evidencing other
necessary corporate action and required governmental and third party approvals,
licenses and consents with respect to this Amendment No. 4 and the transactions
contemplated hereby.

             (b) A certificate of the Secretary or an Assistant Secretary of
Borrower and each Guarantor certifying the names and true signatures of the
officers of Borrower and each Guarantor who have been authorized to execute on
behalf of Borrower and each Guarantor this Amendment No. 4 and any other
agreement, instrument or document executed or to be executed by Borrower or any
Guarantor in connection herewith.

                                     - 6 -
<PAGE>   9

             (c) A certificate dated the Amendment No. 4 Effective Date signed
by the President or any Vice-President of Borrower, to the following effect:

                                    (i) The representations and warranties of
                  the Borrower contained in Sections 3.1, 3.2, and 3.3 of this
                  Amendment No. 4 are true and correct on and as of such date as
                  though made on and as of such date;

                                    (ii) No Default or Event of Default has
                  occurred and is continuing, and no Default or Event of Default
                  would result from the execution and delivery of this Amendment
                  No. 4 or the other agreements, instruments and documents
                  contemplated hereby; and

                                    (iii) The Borrower has paid or agreed to pay
                  all amounts payable by it pursuant to the Agreement as amended
                  hereby (including, without limitation, all legal fees and
                  expenses of Banks' counsel incurred in connection herewith) to
                  the extent then due and payable.

             (d) Executed Modifications to Term Loan Notes in the form attached
hereto as EXHIBIT 1.

             (e) Guaranty and Suretyship Agreement executed by each Guarantor,
in substantially the form of EXHIBIT 2 hereto.

             (f) Amendment to Amended and Restated Pledge Agreement executed by
the Borrower, in favor of the Agent for the benefit of the Banks, in
substantially the form of EXHIBIT 3 hereto, pledging all of the outstanding
stock of each Guarantor, together with the originals of such certificates and
executed stock powers of attorney.

                                     - 7 -
<PAGE>   10

             (g) A favorable opinion of Messrs. Baker Donelson Bearman &
Caldwell, counsel to the Borrower, in substantially the form of EXHIBIT 4
hereto, and as to such other matters as any Bank, through the Agent, may
reasonably request.

             (h) Evidence satisfactory to the Bank that the Borrower has closed
the sale of additional stock in Borrower to investors in an amount sufficient to
net to the Borrower no less than Fourteen Million and No/100 Dollars
($14,000,000.00) in cash proceeds.

         5. EFFECTIVENESS OF AMENDMENT NO. 4. This Amendment No. 4 shall become
effective at such time as (a) each of the conditions precedent set forth in
Section 4.1 hereof shall have been satisfied, and (b) counterparts of this
Amendment No. 4, executed and delivered by the Borrowers, the Guarantors, the
Banks, and the Agent shall have been received by the Agent (or, alternatively,
confirmation of the execution hereof by such parties shall have been received by
the Agent). The date upon which the conditions described in clauses (a) and (b)
of the foregoing sentence shall have been fulfilled is referred to herein as the
"Amendment No. 4 Effective Date".

         6. CLOSING. The Closing under this Amendment No. 4 shall occur on the
Amendment effective Date at the offices of Boult, Cummings, Conners & Berry,
PLC, 414 Union Street, Nashville, Tennessee 37219, or such other location as the
parties may agree.

         7. GOVERNING LAW, ETC. This Amendment No. 4 shall be governed by, and
construed in accordance with, the laws of the State of Tennessee as provided in
Section 10.9 of the Agreement, which Section is incorporated herein by reference
and made a part hereof as though set forth in full herein.

                                     - 8 -
<PAGE>   11

         8. SECTION TITLES AND TABLE OF CONTENTS. The Section Titles and Table
of Contents contained in this Amendment No. 4 are and shall be without
substantive meaning or content of any kind whatsoever and are not a part of the
agreement among the parties hereto.

         9. ARBITRATION. Any controversy or claim between or among the parties
hereto including but not limited to those arising out of or relating to this
Instrument, Agreement or document or any related instruments, agreements or
documents, including any claim based on or arising from an alleged tort, shall
be determined by binding arbitration in accordance with the Federal Arbitration
Act (or if not applicable, the applicable state law), the Rules of Practice and
Procedure for the Arbitration of Commercial Disputes of Judicial Arbitration and
Mediation Services, Inc. (J.A.M.S.), and the "Special Rules" set forth below. In
the event of any inconsistency, the Special Rules shall control. Judgment upon
any arbitration award may be entered in any court having jurisdiction. Any party
to this Agreement may bring an action, including a summary or expedited
proceeding, to compel arbitration of any controversy or claim to which this
agreement applies in any court having jurisdiction over such action.

                  (a) Special Rules. The arbitration shall be conducted in the
city of the Borrower's domicile at the time of the execution of this instrument,
agreement or document and administered by J.A.M.S. who will appoint an
arbitrator; if J.A.M.S. is unable or legally precluded from administering the
arbitration, then the American Arbitration Association will serve. All
arbitration hearings will be commenced within 90 days of the demand for
arbitration; further, the arbitrator shall only, upon a showing of cause, be
permitted to extend the commencement of such hearing for up to an additional 60
days. In any such arbitration, the prevailing party will be awarded attorney's
fees, costs of arbitration and all out-of-pocket expenses against the defaulting
party.

                                     - 9 -
<PAGE>   12

                  (b) Reservation of Rights. Nothing in this instrument,
agreement or document shall be deemed to (i) limit the applicability of any
otherwise applicable statutes of limitation or repose or any waivers contained
in this Agreement; or (ii) be a waiver by the Agent or Banks of the protection
afforded to them by 12 U.S.C. '91 or any substantially equivalent state law; or
(iii) limit the right of the Agent or Banks hereto (A) to exercise self help
remedies such as (but not limited to) set off, or (B) to foreclose against any
real or personal property collateral, or (C) to obtain from a court provisional
or ancillary remedies such as (but not limited to) injunctive relief, writ of
possession or the appointment of a receiver. The Agent or Banks may exercise
such self help rights, foreclose upon such property, or obtain such provisional
or ancillary remedies before, during or after the pendency of any arbitration
proceeding brought pursuant to this instrument, agreement or document. Neither
this exercise of self help remedies nor the institution or maintenance of an
action for foreclosure or provisional or ancillary remedies shall constitute a
waiver of the right of any party, including the claimant in any such action, to
arbitrate the merits of the controversy or claim occasioning resort to such
remedies.

         10. COUNTERPARTS. This Amendment No. 4 may be executed in any number of
counterparts and by different parties hereto in separate counterparts, each of
which when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same instrument.

         11. AGREEMENT TO REMAIN IN EFFECT. Except as expressly provided herein,
the Agreement and each other Collateral Document shall be and shall continue in
full force and effect in accordance with its respective terms.

                                     - 10 -
<PAGE>   13

         IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 4
to be executed by their respective officers thereunto duly authorized, as of the
date first above written.

                                            BORROWER

                                            HEALTHGRADES.COM, INC., FORMERLY
                                            SPECIALTY CARE NETWORK, INC.

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

                                            GUARANTORS AND SUBSIDIARIES

                                            HEALTHCARE RATINGS, INC.

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

                                            PROVIDERWEB.NET, INC.

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

                                     - 11 -
<PAGE>   14

<TABLE>
<S>                                         <C>
                                            BANKS

Committed Amount:                           BANK OF AMERICA, N.A., successor
$3,240,000.00                               to NationsBank, N.A., successor to
                                            NationsBank of Tennessee, N.A., as
                                            Agent

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

Committed Amount:
$1,620,000.00                               AMSOUTH BANK

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

Committed Amount:                           PARIBAS
$1,620,000.00

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

Committed Amount:                           KEY CORPORATE CAPITAL INC.,
$1,620,000.00                               A MICHIGAN CORPORATION

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------

                                            AGENT
                                            BANK OF AMERICA, N.A., AS AGENT

                                            BY:
                                                ------------------------------

                                            TITLE:
                                                   ---------------------------
</TABLE>

                                      -12-<PAGE>   1
                                                                     EXHIBIT 4.1

                            GERIMED OF AMERICA, INC.
                          SECURITIES PURCHASE AGREEMENT

         THIS SECURITIES PURCHASE AGREEMENT ("Agreement") is entered into as of
the 22nd day of December, 1997, by and among GERIMED OF AMERICA, INC., a
Colorado corporation (the "Company"), and SPECTRUM HEALTHCARE SERVICES, INC., a
Delaware corporation ("Investor").

                                    RECITALS:

         A. The Company and Investor deem it advisable for Investor to purchase
and the Company to sell to Investor the Preferred Shares and Warrant (each as
defined below), all upon the terms and subject to the conditions herein
provided.

         B. The Company and Investor are entering into this Agreement for the
purpose of setting forth the terms on which the Investor is willing to purchase
the Preferred Shares and Warrant.

         NOW, THEREFORE, in consideration of the mutual promises and other
consideration hereinafter set forth, the adequacy and receipt of which is hereby
acknowledged by the parties hereto, the parties agree as follows:

         1. SALE AND PURCHASE OF SECURITIES.

         1.1 Sale and Purchase of Securities. The Company agrees to issue and
sell to the Investor, and, subject to all of the terms and conditions hereof and
in reliance on the representations and warranties set forth herein, the Investor
agrees to purchase from the Company, (a) nine hundred six thousand eight hundred
ninety-one (906,891) shares of series A Convertible Preferred Stock, par value
$0.0001 per share, of the Company (the "Preferred Shares"), and (b) a Warrant
substantially in the form of Exhibit A hereto (the "Warrant").

         1.2. Purchase Price.. The purchase price for the Preferred Shares shall
be for the Preferred Shares shall be Three Million Dollars ($3,000,000) and the
purchase price for the Warrant shall be One Hundred Dollars ($100.00), which
prices the parties agree are the fair market value thereof on the Closing Date
and will be treated and reported as such by the parties hereto for U.S. federal,
state and local tax purposes. The aggregate purchase price payable by the
Investor hereunder is Three Million One Hundred Dollars ($3,000,100) (the
"Purchase Price").

         1.3 Closing.

             (a) The closing of the purchase and sale of the Preferred Shares
and Warrant (the "Closing") will take place at the Offices of Thompson Coburn,
One Mercantile Center, Suite 3300, St. Louis, Missouri, on December _, 1997, or
at such other place and date as the Company and the Investor may agree (the
"Closing Date").

             (b) At the Closing, the Company will deliver to the Investor the
Preferred Shares and the Warrant to be issued to Investor against payment by
Investor of the Purchase Price therefor by wire transfer. The Preferred Shares
and the Warrants to will be issued to the Investor on or before the Closing Date
and registered in the Investor's name in the Company's records.

         1.4 Additions Investment. The Investor shall have the right and option,
hereby granted by the Company. to invest an additional. Three Million Dollars
($3,000,000) in the Company (the "Additional Investment"), such right and option
to be exercisable by written,! notice delivered by the Investor to the Company
(the "Investment Notice") no later than the date which is the last day of the
30th full calendar month after the Closing. In exchange for the Additional
Investment the Investor shall. receive from the Company, and the Company

<PAGE>   2

shall issue to the Investor, the number of shares of Series A Convertible
Preferred Stock determined by the following formula:

                  $3.0 million
                  ------------
                  $3.308 x (1 .0 + Premium)

The term "Premium" shall be the number set forth in the following table (with
months being full calendar months after the month in which Closing occurs) for
the period in which the Investment Notice is delivered:

<TABLE>
<CAPTION>

                  If the Investment
                  Notice is delivered:                                                    The Premium is:
                  --------------------                                                    ---------------

<S>                                                                                       <C>
          On or before 12 months after Closing                                                 0.15
          After 12, but on or before 18 months after Closing                                   0.25
          After 18, but on or before 24 months after Closing                                   0.35
          After 24. but on or before 30 months after Closing                                   0.45
</TABLE>

The closing of the Additional Investment shall occur at the Company's principal
office on the business day designated by the Investor that is within forty-five
(45) days after delivery of the Investment Notice. At such closing, (i) the
Company will issue and deliver to the Investor the shares of Series A
Convertible Preferred Stock to which it is entitled under this Section 1.4,
against payment by the Investor of the Additional Investment by wire transfer,
and (ii) the Company shall deliver to the Investor a certificate of its chief
executive officer to the effect that the representations and warranties in
Section 2 below are true and correct. If the Company is unable to deliver such
certificate, then the Investor shall have the right to withdraw the investment
Notice.

         1.5 Future Capital Requirements

         (a) If, within twelve (12) months after the Closing. the Board of
Directors determines that the Company requires additional capital of $3,000,000
or less for any corporate purpose, then the Company may offer shares of common
stock to its existing shareholders (including the Investor), on a pro rata basis
based on the relative holdings of the shareholders of the common stock of the
Company (assuming all Preferred Shares have been converted), for a period of not
more than sixty (60) days, at a price per share not less than (i) $3.308, if
such offering is commenced within six (6) months after the Closing Date, or (ii)
$3.804, if such offering is commenced after the date which is six (6) months
after the Closing Date. Such offeree shareholders may assign their right to
acquire shares of common stock with the consent of the Company, which may be
withheld in the Company's sole discretion.

         (b) After the expiration of twelve months from the Closing, if the
Company proposes to issue any shares of common stock (or options, warrants or
other rights or convertible securities exercisable for or convertible into
common stock) of the Company in a bona fide transaction that is otherwise
permissible under this Agreement and in which the offering price is less than
$3.308 per common share (adjusted equitably for stock splits, reverse stock
splits, subdivisions, reclassifications and similar capital transactions), the
Company shall notify the Investor at least thirty (30) days prior to such
proposed issuance, setting forth in reasonable detail the proposed terms and
conditions of such offering, including without limitation the identity of the
proposed recipient. The investor shall have the right, hereby granted by the
Company, to purchase all or its pro rata portion (on a fully diluted basis
assuming the conversion of all outstanding Preferred Shares, exercise and
conversion of the Warrant and the Warrant Shares, to the extent the Warrant is
then exercisable, and exercise or options having a strike price less than or
equal to the offering price) of such offered securities for cash at the price
specified in the Company's notice. The Investor may exercise such right by
delivery of written notice to the Company within thirty (30) days after the.
Company's delivery of the notice, and the closing of a purchase by the Investor
shall occur within thirty (30) days after such notice of exercise on the
business day specified by the Investor. The notice and purchase opportunity
provisions of this subsection 1.5(b) shall not apply to issuances of shares
pursuant to the exercise of options granted under the option plan described in
Schedule 2.4(b). If the Investor elects to purchase only its pro rata portion of
such offered securities, the Company may sell the remaining securities at the
same price at any time within 180 days after the Investor's delivery of its
notice, without re-offering them to Investor.

<PAGE>   3

         (c) If the Company proposes to issue any shares of common stock (or
options. warrants or other rights or convertible securities exercisable for or
convertible into common stock) of the Company in a transaction that is otherwise
permissible under this Agreement and that is not covered by subsection 1.5(a) or
(b) above, the Company shall notify the Investor of such proposed issuance in
writing at least thirty (30) days prior to such proposed issuance, setting forth
in reasonable detail the proposed terms and conditions thereof, including
without limitation the identity of the proposed recipient (the "Issuance
Notice"). The Investor shall have the right, hereby granted by the Company, to
purchase a portion of such offered securities sufficient to enable the Investor
to maintain its percentage interest in the common equity of the Company (on a
fully diluted basis assuming the conversion of all outstanding Preferred Shares
and exercise and conversion of the Warrant and the Warrant Shares, to the extent
the Warrant is then exercisable) immediately prior to such issuance. Such right
of purchase shall be at the same price, on the same terms and at the same time
as the securities are to be issued to the proposed recipient (except that
noncash consideration to be paid by the proposed recipient shall be valued at
its fair market value cash equivalent for purposes of the price per share to be
paid by the Investor). The Investor may exercise its right in this subsection
(c) by delivery of written notice to the Company within thirty (30) days after
delivery of the Issuance Notice. The notice and purchase opportunity provisions
of this subsection 1.5(c) shall not apply to issuances of shares pursuant to the
exercise of options granted under the option plan described in Schedule 2.4(b)

         (d) For purposes of Section 7.9(f) below, any shares offered to the
Investor under subsection 1.5(a), (b) or (c) which are not purchased by the
Investor shall be "Declined Shares."

         2. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

         The Company hereby represents and warrants to the investor as follows:

         2.1 Organization and Standing: Charter and By-Laws The Company and the
Subsidiary described in Section 2.3 are duly incorporated, validly existing and
in good standing under the laws of the State of Colorado. The Company and
Subsidiary each has full corporate power and authority to own its properties and
carry on its business as it is currently being conducted by the Company and as
is currently proposed to be conducted by the Company. The Company and Subsidiary
each is duly licensed or qualified to transact business as a foreign corporation
and is in good standing in all other jurisdictions in which the nature of the
business transacted by it or the character of the properties owned or leased by
it requires such licensing or qualification, except where the failure to be so
qualified will not have a material adverse effect on the Company or Subsidiary,
as applicable. The Company has furnished the Investor with true, correct and
complete copies of its Articles of Incorporation, as amended (the "Articles"),
and By-Laws, as presently in effect (the "By-Laws").

         2.2 Corporate Power and Authority. The Company has full corporate power
and authority to enter into this Agreement and the transactions contemplated
hereby, issue the Preferred Shares, the Warrants, the shares of Series A
Convertible Preferred Stock issuable upon exercise of the Warrant (the "Warrant
Shares") and the shares of common stock of the Company issuable upon conversion
of the Preferred Shares and Warrant Shares, and to carry out and perform its
obligations under the terms of this Agreement.

         2.3 Subsidiaries. The Company has no subsidiaries and does not own of
record or beneficially any capital stock, assets comprising the business of or
equity interest or investment in any corporation, association or business
entity, except for its wholly owned subsidiary Geriatric Rehab Service, Corp., a
Colorado corporation (the "Subsidiary").

         2.4 Capitalization.

             (a) The authorized capital stock of the Company consists solely of
(i) 5,000,000 shares of preferred stock, par value $0.0001 per share, of which
3,000,000 shares have been designated Series A Convertible Preferred Stock with
the characteristics set forth in Exhibit B and none of which are outstanding,
and (ii) 25,000,000 shares of common stock, $0.0001 par value per share, of
which 4,340,000 are issued and outstanding as of the date hereof All such issued
and outstanding shares are duly authorized and validly issued, fully paid and
nonassessable and owned of record and beneficially by the shareholders and in
the amounts set forth in Schedule 2.4(a) and have

<PAGE>   4

been offered, issued, sold and delivered by the Company in compliance with
applicable federal and state securities laws.

             (b) Except as specified in the Articles, this Agreement, the
Shareholders Agreement described in Section 5.6 or the option plan described in
Schedule 2.4(b) there are no outstanding preemptive, conversion or other rights,
options, warrants or agreements granted or issued by or binding upon the Company
or, to the Company's knowledge, any shareholder for the purchase or acquisition
of any shares of the Company's capital stock. To the best of the Company's
knowledge, no shareholder has granted options or other rights to purchase any
shares of common stock from such shareholder other than as set forth in Schedule
2.4(b). The Company holds no shares of its capital stock in its treasury.

         2.5 Financial Information. The audited consolidated financial
statements of the Company as of and for the fiscal year ended December 3 1, 1996
and the unaudited consolidated financial statements of the Company as of and for
the ten month period ended October 31, 1997, all of which are included in
Schedule 2.5. present fairly the consolidated financial position and results of
operations of the Company and Subsidiary at the dates and for the periods. to
which they relate, have been prepared in accordance with generally accepted
accounting principles consistently applied throughout the periods indicated, and
show all material liabilities, absolute or contingent, of the Company .1 and
Subsidiary required to be recorded thereon in accordance with generally accepted
accounting principles as at the respective dates thereof

         2.6 Outstanding Debt. The Company has no outstanding indebtedness for
borrowed money except as set forth in Schedule 2.6, and is not a guarantor
contingently liable for any material indebtedness of any other party. Except as
set forth in Schedule 2.6. there exists no default by the Company under the
provisions of any instrument evidencing any indebtedness or of any agreement
relating thereto nor has any event occurred that, with notice or passage of time
or both, would constitute such a default by the Company.

         2.7 Absence of Undisclosed Liabilities. To the Company's knowledge,
except as set forth on Schedule 2.7, the Company and Subsidiary have no
liabilities (fixed, accrued, contingent or otherwise, including any tax
liabilities due) which are not fully reflected or provided for on the most
recent balance sheet referred to in Section 2.5. except liabilities incurred in
the ordinary course of business since the date of such balance sheet, none of
which individually or in the aggregate has been or is materially adverse to the
condition, financial or otherwise, of the Company, the Subsidiary or their
assets, properties or business.

         2.8 Absence of Certain Changes. Except to the extent described in
Schedule 2.1, since October 31, 1997 there has not been:

             (a) to the Company's knowledge, any material adverse change in the
condition, financial or otherwise, of the Company or Subsidiary or their assets,
liabilities, properties or business;

             (b) any damage, destruction or loss of any of the tangible assets
of the Company or subsidiary (whether or not covered by insurance) materially
adversely affecting the condition, financial or otherwise, of the Company or
Subsidiary or their assets, liabilities, properties or business;

             (c) any declaration, setting aside or payment of any dividend or
other distribution in respect of any of the Company's capital stock or any
direct or indirect redemption, purchase or other acquisition of any such stock
by the Company;

             (d) any increase in the compensation payable or to become payable
by the Company or Subsidiary to any of its directors, officers, agents,
consultants or any of its employees whose total compensation after such increase
was in excess of One Hundred Thousand Dollars ($100,000) per annum, or any
bonus, percentage compensation, service award or other like benefit having a
value in excess of twenty-five Thousand Dollars ($25,000) granted, made or
accrued to the credit of any such director, officer, agent, consultant or
employee, or any welfare, pension, retirement or similar payment or arrangement
made or agreed to by the Company or Subsidiary for the benefit of any such
director, officer, agent, consultant or employee;

<PAGE>   5

             (e) any change in any method of accounting or accounting practice
of the Company or Subsidiary;

             (f) any notes or accounts receivable or portions thereof written
off by the Company or Subsidiary as uncollectible (except for write-offs in the
ordinary course of business and consistent with past practice);

             (g) any issuance or sale by the Company of any stock, bonds or
other corporate securities of which the Company is the issuer, or the grant,
issuance or change of any stock options, warrants or other rights to purchase
securities;

             (h) any discharge or satisfaction by the Company or Subsidiary of
any lien or encumbrance or payment or satisfaction of any material obligation or
liability (whether absolute, accrued, contingent or otherwise and whether due or
to become due) other than current liabilities shown on the most recent balance
sheet referred to in paragraph 2.5 and current liabilities incurred since the
date of such balance sheet, in the ordinary course of business and consistent
with past practice;

             (i) any sale, assignment, transfer, mortgage, pledge or encumbrance
of any material portion of the assets (real, personal or mixed., tangible or
intangible) of the Company or Subsidiary, cancellation of any material debts or
claims or waiver of any rights of substantial value, except, in each case, in
the ordinary course of business and consistent with past practice;

             (j) any capital expenditure, or commitment to make any capital
expenditure, by the Company or Subsidiary for additions to property, plant or
equipment, individually or in the aggregate in excess of twenty-five Thousand
Dollars ($25,000);

             (k) any change to a contract or arrangement by or to which the
Company or Subsidiary or any of its assets is bound or subject which the Company
reasonably anticipates will have a material adverse effect on the Company or
Subsidiary or its business; or

             (1) to the Company's knowledge, any other event or condition of any
character, materially adversely affecting the condition. financial or otherwise,
of the Company or Subsidiary or their assets, liabilities, properties or
business.

         2.9 Contracts. Except as set forth in Schedule 2.9. neither the Company
nor the Subsidiary is a party to or bound by any written or oral contracts,
obligations, agreements, plans, arrangements, commitments, or the like (absolute
or contingent) of any material nature, including the following, to the extent
material:

             (a) Employment, bonus or consulting agreements, pension, profit
sharing, deferred compensation, stock bonus, retirement, stock option, stock
purchase, phantom stock or similar plans, including agreements evidencing rights
to purchase securities of the Company, agreements among shareholders and the
Company and, to the best knowledge of the Company, agreements among shareholders
of the Company relating to any of the Company's capital stock or rights with
respect thereto;

             (b) Loan or other agreements, notes, indentures or other
instruments relating to or evidencing indebtedness for borrowed money or
mortgaging, pledging or granting or creating a lien or security interest or
other encumbrance on any of the Company's or Subsidiary's property or any
agreement or instrument evidencing any guaranty by the Company or Subsidiary of
payment or performance by any other person,

             (c) Agreements with physician independent contractors or groups
thereof;

             (d) Agreements with hospitals, clinics, pharmacies and other
nonphysician providers of health cue services;

<PAGE>   6

             (e) Agreements with any labor union or collective bargaining
organization or other labor agreements;

             (f) Any indenture or agreement relating to the sale or repurchase
of any securities of the Company (other than this Agreement);

             (g) Any. joint venture contract or arrangement or other agreement
involving a sharing of profits or expenses to which the Company or Subsidiary is
a parry;

             (h) Agreements limiting the freedom of the Company or Subsidiary to
compete in any line of business or in any geographic area or with any person;

             (i) Agreements (other than this Agreement) providing for
disposition of the business, assets or shares of the Company, agreements of
merger or consolidation to which the Company or Subsidiary is a party or letters
of intent with respect to the foregoing; and

             (j) Letters of intent or agreements with respect to the acquisition
of .he business, assets, or shares of any other business.

The Company and Subsidiary each has complied in all material respects with the
provisions of all said contracts, obligations, agreements, plans, arrangements
and commitments to which it is a party, and is not in material default
thereunder. Neither the Company nor the Subsidiary has any present expectation
or intention of not fully performing all its material obligations under each
such contract, obligation or agreement, and the Company has no knowledge of any
breach or anticipated breach by the other party to any material contract or
commitment to which the Company or Subsidiary is a party.

         2.10 Shareholders, Directors and Officers: Indebtedness; Competitors
Set forth on Schedule 2.10 is a correct and complete list or description of all
material indebtedness of the Company and Subsidiary to its officers, directors
or shareholders or any of their respective relatives and of all indebtedness of
such persons to the Company or Subsidiary, excluding travel and business expense
advances made in the ordinary course of business. Except as set forth in
Schedule 2.10 to the best of the Company's knowledge, none of the officers.
directors. employees or consultants of or to the Company or Subsidiary, or their
respective spouses or relatives, (a) owns directly or indirectly, individually
or collectively, a material interest in an. y entity which is a competitor,
customer or supplier of the Company or Subsidiary, or (b) has any existing
contractual relationship with the Company or Subsidiary that is not clearly
disclosed elsewhere in this Agreement.

         2.11 Litigation and Bankruptcy Proceedings.

             (a) Except as set forth in Schedule 2. 11 (a) there is neither
pending nor. to the Company's knowledge, threatened any action, suit, proceeding
or claim, nor any basis therefor, whether or not purportedly on behalf of the
Company or Subsidiary, to which the Company or Subsidiary is or may be named as
a party or its property or assets is or may be subject. The Company has no
knowledge of any unasserted claim, the assertion of which is likely and which,
if asserted, will seek damages, an injunction or other legal, equitable,
monetary or non-monetary relief which claims. individually or collectively with
other such unasserted claims, if granted would have a material adverse effect on
the condition, financial or otherwise, or operations of the Company or
Subsidiary.

             (b) Neither the Company nor the Subsidiary has admitted in writing
its inability to pay its debts as they become due, filed or consented to the
filing against it of a petition in bankruptcy or a petition to take advantage of
any insolvency act, made an assignment for the benefit of creditors, consented
to the appointment of a receiver for itself or for the whole or any substantial
part of its property or assets or had a petition in bankruptcy filed against it,
been adjudicated a bankrupt, or filed a petition or answer seeking
reorganization or arrangement under the federal bankruptcy laws or any other law
or statute of the United States of America or any other jurisdiction.

<PAGE>   7

         2.12 Title to Properties: Liens and Encumbrances The Company and
Subsidiary each has a valid ownership interest in all of its property and
assets, free from all mortgages, pledges, liens, security interests, conditional
sale agreements, encumbrances or charges, except as listed on Schedule 2.12
hereto. The Company and Subsidiary do not have any ownership interest in red
property except as listed on Schedule 2.12 hereto, To the Company's knowledge,
neither the Company nor the Subsidiary is in violation of any law, regulation or
ordinance (including laws, regulations or ordinances relating to building,
zoning, environmental, city planning, land use or similar matters) relating to
its property or assets which violation would have a material adverse effect on
the business of the Company or Subsidiary. All personal property and assets
material to the business.. operations or financial condition of each of the
Company and Subsidiary, and all buildings, structures and fixtures used by it in
the conduct of its business, are in good operating condition and repair relative
to their years of service.

         2.13 Franchises, Licenses. Trademarks, Patents and Other Rights. Except
as set forth on Schedule 2.13 the Company and Subsidiary each has all
franchises, permits, licenses and other similar authority necessary for the
conduct of its business as conducted by it, the lack of which could materially
and adversely affect the operations or condition, financial or otherwise, of the
Company or Subsidiary. Neither the Company nor the Subsidiary is in default in
any material respect under any of such franchises, permits, licenses or other
similar authority. Set forth on Schedule 2.13 to the Company's knowledge are all
patents, patent rights, trademarks, trademark rights, trade names, trade name
rights,, and copyrights owned or used by the Company or Subsidiary (the
"Intellectual Property Rights"), and all such Intellectual Property Rights are
valid and in good standing and adequate and sufficient to permit the Company or
Subsidiary to conduct its business as conducted by it without conflict with or
infringement upon any valid rights of others. No patents, patent rights,
trademarks, trademark rights, trade names, trade name rights or copyrights
(other than those set forth on Schedule 2.13) are required by the Company or
Subsidiary in connection with the conduct of its business as presently conducted
by it. Except as set forth in Schedule 2,13, the Company is not aware of and has
not received any notice of infringement upon or conflict with the asserted
proprietary rights of others. Except as set forth on Schedule 2.13, to the
Company's knowledge, all Intellectual Property Rights owned or used by the
Company or Subsidiary are owned by it free of any adverse claims, rights or
encumbrances as to their exclusive rights thereto, and each of them has used
reasonable efforts to protect its rights to continued secrecy thereof. Except as
set forth on Schedule 2.13. there exist no options, licenses or agreements of
any kind concerning or relating to the Intellectual Property Rights and to which
the Company or Subsidiary is bound.

         2.14 Issuance Taxes. All taxes imposed upon The Company by law as a
result of the issuance, sale and delivery of the Preferred Shares and Warrant
will be fully paid, and all laws imposing such taxes will be fully complied
with, on or prior to the Closing Date.

         2.15 Offering Neither the Company nor anyone authorized to act on its
behalf has taken any action that will cause the issuance, sale and delivery of
the Preferred Shares, Warrant, the Warrant Shares issuable upon exercise of the
Warrant or the common stock issuable upon conversion of the Preferred Shares and
Warrant Shares as contemplated by this Agreement (assuming the truth and
accuracy of the representations and warranties of the Investor set forth in
paragraph 4 hereof), to constitute a violation of the 1933 Act (as defined
below) or any applicable state securities laws.

         2.16 Compliance. The Company is not in violation of any term of the
Articles or its By-Laws as amended. The Company is not in violation of any term
of any law, judgment, decree, order, rule or regulation to which the Company is
subject and a violation of which would have a material adverse effect on the
condition, financial or otherwise, or operations of the Company.

         2.17 Employees. Set forth on Schedule 2,17 is a list of all employment
agreements of the Company or Subsidiary with full-time employees not terminable
at will without continuing obligation to the Company. Except as set forth on
Schedule 2.17, to the Company's knowledge, no full-time employee of the Company
has any affiliation with or obligation to any other employer. The Company is not
aware that any officer or key employee of the Company or Subsidiary intends to
terminate his or her employment, nor does the Company have a present intention
to terminate the employment of any officer or key employee. To the best of the
Company's knowledge, no employee of the Company or Subsidiary is in violation of
any term of any employment contract, patent disclosure agreement,
non-competition agreement or any other contract or agreement or any restrictive
covenant relating to the relationship of any such employee to the Company or any
former employer because of the

<PAGE>   8

nature of the business conducted or contemplated to be conducted by the Company
or the use of trade secrets or proprietary information of others. There is
neither pending nor, to the Company's knowledge, threatened, any action, suit,
proceeding or claim, or to its knowledge, any basis therefor, with respect to
any contract, agreement, covenant or obligation referred to in this Section
2.17.

         2.18 Registration Rights. Except as provided for in this Agreement, the
company is not under any obligation to register any currently outstanding
securities under the 1933 Act.

         2.19 Investments in Other Persons. Except as set forth on the most
recent balance sheet referred to in Section 2.5, the Company and Subsidiary have
not made any loan or advance to any person or entity that is outstanding on the
date of this Agreement, nor is the Company or Subsidiary obligated or committed
to make any such loan or advance, except for advances to employees in the
ordinary course of business, consistent with past practice.

         2.20 Books and Record. The books of account, stock record books, minute
books, bank accounts and other corporate records of the Company and Subsidiary
are true, correct and complete in all material respects and have been maintained
in accordance with sound business practices.

         2.21 ERISA. Except as set forth on Schedule 2.21. the Company and
Subsidiary do not maintain any employee pension benefit plan as defined in
section 3(2)(A) of Title I of the Employee Retirement Income Security Act of
1974, as amended. The Company is in compliance in all material respects with all
its obligations pursuant to such plans.

         2.22 Use of Proceeds. The Company will use the proceeds from the sale
of the Preferred Shares and Warrant for the purpose of repaying existing
indebtedness, and for general corporate purposes.

         2.23 Company Information Listed on Schedule 2.13 is a list of (a) the
name of each of the Company's and Subsidiary's directors as of the date of this
Agreement, and (b) the name and title of each of the Company's and Subsidiary's
officers as of the, date of this Agreement.

         2.24 Authorization; No Conflicts All corporate action on the part of
the Company, its directors and shareholders necessary for the authorization,
execution, delivery and performance by the Company of this Agreement, the
Preferred Shares and the Warrant, and, subject to the exercise of the Warrant in
accordance with its terms, the issuance of the Warrant Shares, has been taken.
This Agreement is the valid and binding obligation of the Company, enforceable
in accordance with its terms, subject to laws of general application relating to
bankruptcy, insolvency and the relief of debtors and to general principles of
equity. The execution, delivery and performance by the Company of this Agreement
and compliance herewith and the issuance of Preferred Shares, Warrant and
Warrant Shares (and the common stock issuable upon conversion of the Preferred
Shares and Warrant Shares) will not, assuming the truth and accuracy of the
Investor's representations and warranties set forth in paragraph 4 hereof result
in any violation of and will not conflict with, or result in a breach of or any
violation of and will not conflict with, or result in any breach of any of the
terms of, or constitute a default under, any provision of federal or state law
to which the Company is subject, the Company's Articles of Incorporation or
By-Laws, or any mortgage, indenture, agreement instrument, judgment, decree,
order, rule or regulation or other restriction to which the Company is a party
or by which it is bound or result in the creation of any mortgage, pledge, lien,
encumbrance or charge upon any of the properties or assets of the Company
pursuant to any such term. The Warrant Shares (and the common stock issuable
upon conversion of the Preferred Shares and Warrant Shares) have been duly and
validly reserved and are not subject to any preemptive rights or rights of first
refusal and, upon issuance in accordance with this Agreement will be validly
issued, fully paid and nonassessable.

         2.25 Taxes. The Company and Subsidiary each has filed within the time
prescribed by law (including extensions of time approved by the appropriate
taxing authority) all tax returns and reports required to be filed with the
United States Internal Revenue Service, with the State of Colorado and with all
other jurisdictions where such filing is required by law. The Company and
Subsidiary each has paid or, and as to the extent required by generally accepted
accounting principles, made adequate provision in the most recent balance sheet
referred to in Section 2.5 for the payment of, all taxes, interest, penalties,
assessments or deficiencies shown to be due or claimed

<PAGE>   9

to be due on or in respect of such tax returns and reports. The Company knows of
(a) no other tax returns or reports which are required to be filed which have
not been so filed and (b) no unpaid assessment for additional tax for any fiscal
period or any basis therefor. The Company's tax returns have not been audited by
the United States Internal Revenue Service nor by any state taxing authority.

         2.26 Insurance. The Company maintains indemnity insurance for its
directors and officers and maintains other insurance covering the Company's and
Subsidiary's business and personnel risks which is customary in its industry and
which the Company believes is commercially reasonable given the risks involved
in the business conducted by the Company and Subsidiary.

         2.27 Environmental and Safety Laws. Neither the Company nor the
Subsidiary is in violation of any applicable statute, law or regulation relating
to the environment or occupational health and safety, which violations, either
singly or in the aggregate, would have a material adverse effect en the
Company's or Subsidiary's business, and no material expenditures am required in
order to comply with any such statute, law or regulation.

         2.28 Disclosure. Neither this Agreement, nor any certificate or
statement furnished to the Investor by the Company pursuant to this Agreement,
when considered as a whole, contains any untrue statement of a material fact,
and none of this Agreement, such certificates or statements omits to state a
material fact necessary in order to make the statements contained herein or
therein not misleading, in the light of the circumstances under which they were
made.

         3. REPRESENTATIONS AND WARRANTIES OF THE INVESTOR

         The Investor represents and warrants to the Company that the Investor
is duly organized and in good standing under the laws of the State of Delaware
and that all corporate action on the part of the Investor necessary for the
authorization, execution, delivery and performance of all its obligations under
this Agreement has been taken. This Agreement constitutes a valid and legally
binding obligation of the Investor enforceable in accordance with its terms,
subject to laws of general application relating to bankruptcy, insolvency and
tile relief of debtors and to general principles of equity. The execution,
delivery and performance by the Investor of this Agreement and compliance
herewith will not conflict with, or result in any breach of any of the terms of,
or constitute a default under, any provision of federal or state law to which
the Investor is subject, the Investor's Certificate of Incorporation or By-Laws,
or any mortgage, indenture, agreement, instrument, judgment decree, order, rule
or regulation or other restriction to which the Investor is a party or by which
it is bound. To the Investor's knowledge, the Investor does not own, directly or
indirectly, a material interest in any entity which is a competitor, customer or
supplier of the Company.

         4. FEDERAL AND OTHER SECURITIES LAWS.

         4.1 Investment Representations

             (a) This Agreement is made with the Investor in reliance upon the
Investor's representation to the Company, which by its acceptance hereof the
Investor hereby confirms, that the Preferred Shares and Warrant acquired
hereunder, and the Warrant Shares issuable upon exercise of the Warrant (all
such securities are referred to as the "Securities" for purposes of this
paragraph 4) will be acquired by Investor for investment for its own account,
not as a nominee or agent, and not with a view to the sale or distribution of
any part thereof, and that it has no present intention of selling, granting
participation in, or otherwise distributing the same. By executing this
Agreement, the Investor further represents that it has no contract, undertaking,
agreement or arrangement with any person to sell, transfer, or grant
participations to such person or to any third person, with respect to any of the
Securities.

             (b) The Investor understands that the Securities are not registered
under the Securities Act of 1933, as amended (the "1933 Act") on the ground that
the sale provided for in this Agreement and the issuance of Securities hereunder
should be exempt from registration under the 1933 Act and that the Company's
reliance on such exemption is predicated on the Investor's representations set
forth herein. The Investor realizes that the basis for the exemption may not be
present if notwithstanding such representations, Investor has in mind merely

<PAGE>   10

acquiring the Securities for a fixed or determinable period in the future, or
for a market rise or for sale if the market does not rise. The Investor confirms
it has no such intention.

             (c) The Investor represents that it is an "accredited investor"
within the meaning of Rule 501 under the 1933 Act and that it is experienced in
evaluating and investing in companies such as the Company. is able to fend for
itself in the transactions contemplated by this Agreement, has such knowledge
and experience in financial and business matters as to be capable of evaluating
the merits and risks of its investment and has the ability to bear the economic
risks of its investment.

             (d) The Investor understands that the Securities may not be sold,
transferred or otherwise disposed of without registration under the 1933 Act or
an exemption therefrom, and that in the absence of an effective registration
statement covering the Securities or an available exemption from registration
under the 1933 Act, the Securities must be held indefinitely. The Investor
represents that, in die absence of an effective registration statement covering
the Securities it will sell, transfer or otherwise dispose of the Securities
only in a manner consistent with its representations set forth herein and then
only in accordance with the provisions of paragraph 4.1(e) hereof.

             (e) The Investor agrees that in no event will it make a transfer or
disposition of any of the Securities (other than in accordance with the terms of
exercise of the Warrant or pursuant to an effective registration statement under
the 1933 Act), unless and until Investor shall have notified the Company of the
proposed disposition and shall have furnished the Company with a statement of
the circumstances surrounding the disposition and assurance that the proposed
disposition is in compliance with all applicable laws and (ii) if reasonably
requested by the Company, Investor shall have furnished to the Company an
opinion of counsel or other evidence reasonably satisfactory to the Company to
the effect that such transfer may be made without registration under the 1933
Act.

         4.2 Legends Stop Transfer

             (a) All certificates for the Securities may bear the following or a
substantially similar legend.

         "These securities have not been registered under the Securities Act of
         1933. They may not be sold, offered for sale, pledged or hypothecated
         in the absence of an effective registration statement as to the
         securities under said Act or an opinion of counsel or other evidence
         reasonably satisfactory to the Company that such registration is not
         required."

             (b) The certificates for the Securities may also bear any legend
required by any applicable state securities or other law.

             (c) In addition, the Company shall make a notation regarding the
restrictions on transfer of the Securities in its records and the Securities
shall be transferred on the books of the Company only if transferred or sold
pursuant to an effective registration statement under the 1933 Act covering such
shares or in compliance with the provisions of Section 4.1(e) hereof

         5. CONDITIONS TO INVESTOR'S OBLIGATIONS AT CLOSING.

         The obligation of the Investor to purchase the Preferred Shares and
Warrant in accordance with this Agreement are subject to the fulfillment on or
before the Closing Date of each of the following conditions:

         5.1 Representations and Warranties True on The Closing Date. The
representations and warranties of the Company contained in Section 2 shall be
true and correct in all material respects on and as of the Closing Date with the
same force and effect as if they had been made at the Closing Date.

<PAGE>   11

         5.2 Performance. The Company shall have performed and complied in all
material respects with all agreements and conditions contained in this Agreement
required to be performed or complied with by it on or before the Closing Date.

         5.3 Qualifications and Consents. All authorizations, approvals or
permits, if any, of any govern governmental authority or regulatory body of the
United States or of any state and all consents of third parties that are
required in connection with the lawful issuance and sale of the Preferred Shares
and the Warrant and the transactions contemplated hereby, shall have been duly
obtained and shall be effective on and as of the Closing Date.

         5.4 Legal Opinion. The Investor shall have received an opinion of
counsel to the Company. as to the matters in Exhibit C hereto.

         5.5 Proceedings and Documents. All corporate and other proceedings in
connection with the transactions contemplated hereby and all documents and
instruments incident to such transactions shall be in form and substance
reasonably satisfactory to the Investor and the Investor shall have received all
such counterpart originals or certified or other copies of such documents as it
may reasonably request.

         5.6 Shareholders Agreement. The Company and James F. Riopelle shall
have executed and delivered a Shareholders Agreement substantially in the form
of Exhibit D hereto (the "Shareholders Agreement").

         6. CONDITIONS TO THE COMPANY'S OBLIGATIONS AT CLOSING.

         The obligation of the company to issue and deliver the Preferred Shares
and Warrant in accordance with this Agreement are subject to the fulfillment on
or before the Closing Date of each of the following conditions:

         6.1 Representations and Warranties True on the Closing Date. The
representations and warranties of the Investor contained in paragraphs 3 and 4
shall be true on and as of the Closing Date with the same force and effect as if
they had been made at the Closing Date.

         6.2 Performance. Investor shall have performed and complied in all
material respects with all agreements and conditions contained in this Agreement
required to be performed or complied with by it on or before the Closing Date,

         6.3 Qualifications and Consents. All authorizations, approvals or
permits, if any, of any governmental authority or regulatory body of the United
States or of any state and all consents of third parties that are required in
connection with the lawful issuance and sale of the Preferred Shares and the
Warrant and the transactions contemplated hereby, shall have been duly obtained
and shall be effective on and as of the Closing Date.

         6.4 Proceedings and Documents. All corporate and other proceedings in
connection with the transactions contemplated hereby shall be in form and
substance reasonably satisfactory to the Company and the Company shall have
received all such counterpart originals or certified or other copies at such
documents as it may reasonably request.

         6.5 Shareholders Agreement. The Investor shall have executed and
delivered the Shareholders Agreement.

         7. COMPANY COVENANTS AND INDEMNIFICATION

         From and after the Closing Date and continuing until the date specified
in Section 7. 10, the Company shall comply with the provisions of this Section
7.

         7.1 Corporate Existence, etc. The Company will preserve and keep in
force and effect corporate existence and such licenses and permits which are
necessary and material to the proper conduct of its business.

<PAGE>   12

         7.2 Insurance. The Company will maintain insurance coverage by
financially sound and reputable insurers in such forms, against such risks and
with limits of coverage at least equal to existing limits, as am currently
maintained by the Company.

         7.3 Taxes, Claims for Labor and Materials, Compliance with Laws. The
Company will promptly pay and discharge all lawful taxes, assessments and
governmental charges or levies imposed upon the Company or upon or in respect of
all or any part of the material property or business of the Company, all trade
accounts payable in accordance with usual and customary business terms, and all
claims for work, labor or materials, which if unpaid might become a lien or
charge upon any material property of the Company; provided the Company shall not
be required to pay any such tax, assessment charge, levy, account payable or
claim if the validity, applicability or amount thereof is being contested in
good faith by appropriate actions or proceedings and such refusal or failure to
pay such tax, assessment, charge, levy, account payable or claim does not have a
material adverse affect on the condition, financial or otherwise, of the Company
or its assets, liabilities, properties or business.

         7.4 Financial Statements. The Company shall deliver to the Investor:

             (a) within thirty (30) days after the end of each month, an
unaudited balance sheet and income statement for such month;

             (b) within one hundred twenty (120) days after the end of each
fiscal year of the Company an income statement for such fiscal year, a balance
sheet of the Company as of the end of such year and a statement of cash flows
for such year, together with such notes thereto as are appropriate, prepared in
accordance with generally accepted accounting principles consistently applied
and setting forth in each case in comparative form the figures for the previous
year. all in reasonable detail and certified by independent public accountants
of recognized national standing selected by the Company and reasonably
acceptable w the Investor;

             (c) as soon as available, but in any event within sixty (60) days
after commencement of each new fiscal year, a business plan, projected financial
statements and cash flow projections for such fiscal year as set forth in the
Company's operating plan as approved by the Company's Board of Directors, along
with a capital expenditures budget, and

             (d) such other financial statements as Investor may reasonably
request to verify the financial condition of the Company and the valuation of
Investor's investment therein. All such statements shall be certified by the
Chief Financial Officer of the Company as being true, complete and in accordance
with the Company's books and records and regular accounting practices.

         7.5 Inspection. The Company shall permit Investor and its authorized
designees to examine the Company's books of account and records ("Examination"),
to visit and inspect the Company's properties, and to discuss the Company's
affairs, finances and accounts with its employees, officers and independent
accountants, all at such reasonable times during normal business hours as may be
requested by Investor (but limited to two Examinations in any calendar year) and
upon reasonable advance notice given to the Company.

         7.6 Employee Stock Plans. The Company covenants that it will not
increase the number of shares reserved under the stock option plan described in
Schedule 2.4(b) or establish any additional stock plan providing for issuance of
the Company's securities to officers, directors, employees and consultants,
unless (a) such increase in shares or additional plan is approved by the
Company's Board of Directors, (b) the total number of shares of Common Stock
issued or reserved for issuance under all such plans of the Company does not
exceed __% of the fully diluted common equity of the Company, and (c) if all
options under such plan(s) were immediately granted and exercisable, the Company
would be in compliance with Section 7.9(f) below.

         7.7 Capital Expenditures. Each year, as pan of its business plan, the
Company shall submit to its Board of Directors a detailed capital expenditure
budget for the coming year, with such budget to be approved by the Board.

<PAGE>   13

         7.8 Use of Proceeds. The Company agrees that it will use the proceeds
from the sale of the Securities hereunder solely for the purpose of repaying
existing indebtedness, and for general corporate purposes. The Company further
agrees that it will not use any pan of the proceeds from the sale of the
Securities to purchase or carry any "margin security" or "margin stock," as such
terms are defined in any regulation, rule or interpretation of the Board of
Governors of the Federal Reserve System.

         7.9 Negative Covenants. Unless the Company first obtains the written
consent of the Investor, the Company shall not:

             (a) merge, consolidate with or otherwise acquire substantially A of
the assets or securities of any partnership, corporation. firm or other business
enterprise if the acquisition price of such assets or securities exceeds
$1,000,000, nor sell, lease or otherwise dispose of Company assets having a
value in excess of (g) 1,000,000;

             (b) other than in the ordinary course of business or consistent
with the Company's past practice, make any investment in excess of $500,000 in
the securities of any partnership, corporation, firm or other business
enterprise;

             (c) other than in the ordinary course of business consistent with
the Company's past practice, guarantee or otherwise become liable for the
obligations or liabilities of any partnership, corporation, firm or other
business enterprise,

             (d) declare or pay dividends upon any claw of the Company's stock;

             (e) redeem, retire, repurchase or otherwise acquire, directly or
indirectly, any of the Company's stock of any class, except for repurchases from
employees of the Company, other than J.F. Riopelle and any transferee of shares
from J.F. Riopelle, pursuant to the term of the Shareholders Agreement dated as
of January 1, 1994 ("Existing Agreement"), including repurchases from employees
who join the Existing Agreement after the date hereof, as such Existing
Agreement is presently in effect and as hereafter amended with the Investor's
prior written consent, not to be unreasonably withheld;

             (f) issue any of the Company's stock of any class, except (i)
pursuant to the Additional Investment, (ii) in connection with the exercise of
any warrant granted to the Investor, (iii) pursuant to any antidilution or
adjustment provision in this Agreement or any warrant granted to the Investor,
(iv) pursuant to the exercise of options granted under the plan described in
Schedule 2.4(b) or a plan adopted in compliance with Section 7.6, or (v) in
compliance with Section 1.5, provide that any issuance otherwise permissible
under Section 1.5 shall be subject to the Investor's prior written consent
(which may be withheld in its sole discretion) if, immediately following such
issuance, the Investor's "Imputed Common Equity" shall be less than fifty-one
percent (51%); provided further, however, that the Investor's consent to such
issuance shall not be required if the Company grants to the Investor the right
to purchase (under the timetables and procedures in Section 1.5(c) above) not
less than that number of shares offered that, immediately after such purchase,
would cause the Investor's Imputed Common Equity to be fifty-one percent (51%).
The term "Imputed Common Equity" shall mean, a fraction, the denominator of
which is the number of shares of common stock then outstanding (on a fully
diluted basis assuming all options, warrants and other rights have been
exercised and all convertible securities converted), and the numerator of which
is the sum of (A) the shares of common stock owned directly by the Investor, (B)
the shares of common stock receivable by Investor upon conversion of the
Preferred Shares, (C) the shares of common stock receivable by Investor upon
conversion of the Warrant Shares, (D) the shares which the Investor would be
entitled to receive under the Additional Investment, (E) the shares subject to
the Call Option, and (F) the aggregate amount of the Declined Shares;

             (g) cease engaging principally in the business of providing health
care for the senior population;

             (h) amend any provision of the Company's articles of incorporation
or bylaws; or

             (i) consummate any other transaction, directly or indirectly,
through any subsidiaries or affiliates or otherwise, that is principally
designed to circumvent the covenants contained in this Agreement.

<PAGE>   14

         7.10 Termination of Covenants. The covenants set forth in this Section
7 shall terminate and be of no further force or effect after the earlier of (a)
the closing of an initial public offering pursuant to an effective registration
statement under the 1933 Act covering the offer and sale of common stock for the
account of the Company to the public with an aggregate offering price of not
less than Ten Million Dollars ($10,000,000) (a "Qualified Offering", or (b) the
first date on which the Investor holds fewer than five percent (5%) of the
Company's common stock (assuming the conversion of all Preferred Shares and the
exercise and conversion of all Warrant Shares). In addition, the covenants set
forth in Sections 7.1, 7.3, and 7.6 through 7.9, shall expire on the fifth
anniversary of the Closing Date if the Investor (a) does not then own Imputed
Common Equity of fifty-one percent (51%) or more, and (b) has not exercised the
Call Option described in the Shareholders Agreement.

         8. REGISTATION RIGHTS

         8.1 Definitions. For purposes of this Section 8:

             (a) The terms "`register," "registered" and "`registration" refer
to a registration effected by preparing and filing a registration statement in
compliance with the 1933 Act and the declaration or ordering of effectiveness of
such registration statement;

             (b) The term "Registrable Securities" means (1) the common stock
receivable upon conversion of the Preferred Shares, (2) the common stock
receivable upon conversion of the Warrant Shares, (3) the common stock acquired
by a Holder under any provision of this Agreement, and (4) any common stock of
the Company issued as a dividend or other distribution with respect to, or in
exchange or in replacement of, the common stork identified in clauses (1)
through (3); provided, however, shares shall cease being "Registrable
Securities" at such time that they can be re-sold without registration under
Rule 144(k) or any successor rule of the 1933 Act without any volume limitation;
and

             (c) The term "Holder" means the Investor holding Registrable
Securities and any other person holding Registrable Securities to whom these
registration rights have been transferred pursuant to Section 9. 14 of this
Agreement.

         8.2 Company Registration If at any time following the completion by the
Company of an initial public offering of its Common Stock or any other equity
securities under the. 1933 Act, the Company proposes to register any of its
Common Stock or any other class of equity securities under the 1933 Act in
connection with the public offering of such securities solely for cash on a form
that would also permit the registration of the Registrable Securities, the
Company shall, each such time, promptly give each Holder written notice of such
determination. Upon the written request of any Holder given within twenty (20)
days after delivery by recognized overnight delivery service of any such notice
by the Company, the Company shall use all commercially reasonable efforts to
cause to be registered under the 1933 Act all of Registrable Securities that
each such Holder has requested be registered.

         If the registration of which the Company gives notice is for a
registered public offering involving an underwriting, then the Company shaft so
advise the Holders as a part of such written notice. In such event the right of
any Holder to registration pursuant to this Section 8.2 shall be conditioned
upon such Holder's agreeing to participate in such underwriting and the
inclusion of such Holder's Registrable Securities in the underwriting to the
extent provided herein. All Holders proposing to distribute their securities
through such underwriting shall (together with the Company and the other holders
distributing their securities through such underwriting) enter into an
underwriting agreement in customary form with the underwriter or underwriters
selected for such underwriting by the Company. Notwithstanding any other
provision of this Section 8.2, if the underwriter deems it advisable to limit
the number of shares to be underwritten, then the underwriter may exclude some
or all Registrable Securities from such registration and underwriting in
accordance with the provisions of this Section 8.2. The Company shall so advise
all Holders and the other holders distributing their securities through such
underwriting, and the number of Registrable Securities and other securities that
may be included in the registration and underwriting shall be allocated among
the Holders and other shareholders exercising registration rights granted prior
to the date hereof (collectively, the "Selling Holders"), in proportion, as
nearly as practicable, to the respective amounts of securities held by each such
holder at the time of filing the registration statement. Prior to the inclusion
of any shares held by other holders, the

<PAGE>   15

Selling Holders shall be offered the opportunity to include, pari passu, in such
offering all shares which the Selling Holders desire to be so included. If any
Selling Holder or holder disapproves of the terms of any such underwriting, then
he may elect to withdraw therefrom by written notice to the Company and the
underwriter. Any securities excluded or withdrawn from such underwriting shall
be withdrawn from such registration.

         8.3 Obligations of the Company Whenever required under Section 8.2 or
Section 8.10 to use all reasonable efforts to effect the registration of any
Registrable Securities, the Company shall, as expeditiously as reasonably
possible:

             (a) Prepare and file with the SEC a registration statement with
respect to such Registrable Securities and use all reasonable efforts to cause
such registration statement to become and remain effective; provided, however,
that the Company shall in no event be obligated to cause any such registration
to remain effective for more than one hundred eighty (180) days, except as
otherwise required by law. The Company shall promptly notify Holders upon the
effectiveness of such registration statement or the issuance by the SEC of a
stop order with respect to such registration statement.

             (b) Prepare and file with the SEC such amendments and supplements
to such registration statement and the prospectus used in connection with such
registration statement as may be necessary to comply with the provisions of the
1933 Act with respect to the disposition of all securities covered by such
registration statement.

             (c) Furnish to the Holders such numbers of copies of a prospectus,
including a preliminary prospectus, in conformity with the' requirements of the
1933 Act and such other documents as they may reasonably request in order to
facilitate the disposition of Registrable Securities owned by them.

             (d) Use all reasonable efforts to register and qualify the
securities covered by such registration statement under such other securities or
Blue Sky laws of such jurisdictions in which such qualification can be effected
without unreasonable expense as determined by the Board of Directors in its sole
discretion and as shall be reasonably appropriate for the distribution of the
securities covered by the registration statement, provided that the Company
shall not be required in connection therewith or as a condition thereof to
qualify to do business or to file a general consent to service of process in any
such states or jurisdictions, and further provided that (anything in this
Agreement to the contrary notwithstanding with respect to the bearing of
expenses) if any jurisdiction in which the securities shall be qualified shall
require that expenses incurred in connection with the qualification of the
securities in that jurisdiction be borne by selling shareholders, then such
expenses shall be payable by selling shareholders pro rata, to the extent
required by such jurisdiction. Notwithstanding the foregoing, the Company shall
be permitted, at any time, to withdraw or to decline to file a registration
statement proposed under Section 8.2.

         8.4 Furnish Information. It shall be a condition precedent to the
obligations of the Company to take any action pursuant to Section 8 that the
Holders shall furnish to the Company such information regarding them, the
Registrable Securities held by them, and the intended method of disposition of
such securities as the Company shall reasonably request and as shall be required
in connection with the action to be taken by the Company.

         8.5 Expenses of Demand Registration. All expenses incurred in
connection with a registration pursuant to Section 8.10 (excluding underwriters'
discounts and commissions), including without limitation all registration and
qualification fees, printers' and accounting fees, fees and disbursements of
counsel for the Company and (to a maximum of $2,500) the reasonable bees and
disbursements of one counsel for the selling Holders shall be borne by the
Company; provided, however. that the Company shall not be required to pay any
expenses of any registration proceeding begun pursuant to Section 8. 10 if the
registration request is subsequently withdrawn, unless the Holders agree to
forfeit their right to registration pursuant to Section 8,10; and provided
further, that the Holders may withdraw a request made within seventy-five (75)
days of the end of any fiscal year if the audited financial statements of the
Company for such year and at such year-end materially and adversely differ from
the information available to the Molders at the time of their request, in which
event the Holders shall not be required to pay any of the expenses and shall
retain the right to the demand registration which would otherwise have been
forfeited as a result of such withdrawal request.

<PAGE>   16

         8.6 Company Registration Expenses. In the case of any registration
effected pursuant to Section 8.2, the Company shall bear any additional
registration and qualification fees and expenses (including underwriters'
discounts and commissions), and any additional costs and disbursements of
counsel for the Company that result from the inclusion of securities held by the
Holders in such registration. In addition, the Company shall bear the fees and
costs of one counsel for the Selling Holders., to a maximum of $2,500 per
registration.

         8.7 Underwriting Requirements In connection with any offering involving
an underwriting of shares being sold by persons exercising the registration
rights contained in Section 8. 10. the Company shall (together with all holders
proposing to distribute their securities through such underwriting) enter into
an underwriting agreement in customary form with, the representative of the
underwriter or underwriters of recognized national or regional standing,
reasonably acceptable to the Company, selected for such underwriting by a
majority in interest of the Selling Holders. If the representative advises the
Selling Holders in writing that the representative in its sole discretion deems
it advisable to limit the number of shares to be underwritten, them the number
of shares of Registrable Securities that may be included in the registration and
underwriting shall be allocated among all Holders thereof in proportion, as
nearly as practicable, to the respective amount of Registrable Securities held
by such Holders at the time of filing the Registration Statement.

         If the underwriter has not limited the number of Registrable Securities
to be underwritten, then the Company and the other holders may include
securities for their own account in such registration if the underwriter so
agrees and if the number of Registrable Securities that would otherwise have
been included in such registration and underwriting will not thereby be limited
for any reason, including but not limited to the price for which the Registrable
Securities will be sold. To the extent that the underwriter wishes to limit the
number of shares to be included in the registration on behalf of the Company and
the other holders, the shares of Common Stock to be registered held by the other
holders shall be excluded from such offering prior to excluding any shares held
by the Company.

         8.8 Delay of Registration No Holder shall have any right to take any
action to restrain enjoin or otherwise delay any registration as the result of
any controversy that might arise with respect to the interpretation or
implementation of this Section 8.

         8.9 Indemnification In the event any Registrable Securities are
included in a registration statement under Section 8:

             (a) To the extent permitted by law, the Company sill indemnify and
hold harmless each Holder requesting or joining in a registration and each
person, if any, who controls such Holder within the meaning of the 1933 Act,
against any losses, claims, damages or liabilities, joint or several, to which
they may become subject under the 1933 Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or
are based on any untrue or alleged untrue statement of any material fact
contained in such registration statement, including any preliminary prospectus
or final prospectus contained therein or any amendments or supplements thereto,
or arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein., or necessary to make the
statements therein not misleading or arise out of any violation by the Company
of any rule or regulation promulgated under the 1933 Act applicable to the
Company and relating to action or inaction required of the Company in connection
with any such registration; and will reimburse each such Holder, or controlling
person for any legal or other expenses reasonably incurred by them in connection
with investigating or defending any such loss, claim, damage, liability or
action; provided, however, that the indemnity agreement contained in this
Section 8.9(a) shall not apply to amounts paid in settlement of any such loss,
claim, damage, liability or action if such settlement is effected without the
consent of the Company (which consent shall not be unreasonably withheld) nor
shall the Company be liable in any such case for any such loss, claim, damage,
liability or action to the extent that it arises out of or is based upon an
untrue statement or alleged untrue statement or omission or alleged omission
made in connection with such registration statement preliminary prospectus,
final prospectus, or amendments or supplements thereto, in reliance upon and in
conformity with written information furnished expressly for use in connection
with such registration by any such Holder or controlling person or its
representatives.

<PAGE>   17

             (b) To the extent permitted by law, each Holder requesting or
joining in a registration will indemnify and hold harmless the Company, each of
its directors, each of its officers who have signed the registration statement,
each person, if any, who controls the Company within the meaning of the 1933
Act. each agent and any underwriter for the Company (within the meaning of the
1933 Act) and each and every other Selling Holder against any losses, claims,
damages or liabilities to which the Company or any such director, officer,
controlling person, agent or underwriter may become subject, under the 1933 Act
or otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in such registration
statement including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading,
in each case to the extent, but only to the extent, that such untrue statement
or alleged untrue statement or omission or alleged omission was made in such
registration statement, preliminary or final prospectus, or amendments or
supplements thereto, in reliance upon and in conformity with written information
furnished by such Holder or its representatives expressly for use in connection
with such registration; and each such Holder will reimburse any legal or other
expenses reasonably incurred by the Company or any such director, officer,
controlling person, agent or underwriter in connection with investigating or
defending any. such loss, claim, damage, liability or action; provided, however,
that the indemnity agreement contained in this Section 8.9(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of such Holder (which consent
shall not be unreasonably withheld). The Company shall use its best efforts to
obtain similar indemnification undertakings from every other holder exercising
registration rights pursuant to a registration statement for a transaction in
which a Holder participates.

             (c) Promptly after receipt by an indemnified party under this
paragraph of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against any indemnifying party
under this paragraph, notify the indemnifying party in writing of the
commencement thereof and the indemnifying party shall have the right to
participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly noticed, to assume the defense
thereof with counsel mutually satisfactory to the parties. The failure to notify
an indemnifying party promptly of the commencement of any such action, if
materially prejudicial to his ability to defend such action, shall relieve such
indemnifying party of any liability to the indemnified party under this
paragraph, but the omission so to notify the indemnifying party will not relieve
him of any liability that he may have to any indemnified party otherwise than
under this paragraph.

         8.10 Registrations on Form S-3.

             (a) If (i) a Holder or Holders who cannot transfer Registrable
Securities without registration pursuant to Rule 144 promulgated under the 1933
Act request in writing (specifying that it is being made pursuant to this
Section 8.10) that the Company file a registration statement on Form S-3 (or any
successor form to Form S-3 regardless of its designation) for a public offering
of shares of the Registrable Securities the reasonably anticipated aggregate
price to the public of which would exceed $1,000,000 and (ii) the Company is a
registrant entitled to use Form S-3 to register such shares, then the Company
shall use all reasonable efforts to cause such shares to be registered on Form
S-3 (or any successor form to Form S-3); provided, however, that the Company
shall not be required to file more than one such registration statements in any
one calendar year.

             (b) Holders' rights to registration under this Section 8.10 are in
addition to, and not in lieu of, their rights to registration under Section 8.2.

         8.11 Reports Under Securities Exchange Act of 1934. With a view to
making available to the Holders the benefits of Rule 144 promulgated under the
1933 Act and any other rule or regulation of the SEC that may at any time permit
a Holder to sell securities of the Company to the public without registration
and to the extent such Rule is available, the Company agrees to use all
reasonable efforts to (a) make and keep current public information available,
within the meaning of Rule 144 or any similar or analogous rule promulgated
under the 1933 Act at all times after it has become subject to the reporting
requirements of the Securities Exchange Act of 1934, as amended (the "1934
Act"); (b) file with the SEC, in a timely manner, all reports and other
documents required of the Company under the 1933 Act and the 1934 Act (after it
has become subject to such reporting requirements); and (c)

<PAGE>   18

furnish to any Holder, so long as such Holder owns any Registrable Securities,
forthwith upon request a written statement by the Company that it has complied
with the reporting requirements of Rule 144 (at any time after ninety (90) days
after the effective date of said first registration statement filed by the
Company), and of the 1933 Act and the 1934 Act (at any time after it has become
subject to such reporting requirements), a copy of the most recent annual or
quarterly report of the Company and such other reports and documents so filed by
the Company as may be reasonably requested in availing any Holder of any rule or
regulation of the SEC permitting the selling of any such securities without
registration.

         8.12 Certain Limitations in Connection with Future Grants of
Registration Rights From and after the date of this Agreement, the Company shall
not enter into any agreement with any holder or prospective holder of any
securities of the Company providing for the granting to such holder of
registration rights unless such agreement includes a provision that, in the case
of a public offering involving an underwritten registered offering under Section
8.10, protects the Holders if the underwriters require a limitation on the
number of securities to be included in the underwriting in the manner in which
the Company is protected under Section 8.7.

         8.13 Transfer of Registration Rights. The registration rights of the
Investor under this Section 8 may be transferred to any transferee who acquires
the Preferred Shares or an equivalent amount of Registrable Securities;
provided, however, that the Company is given written notice by the Holder at the
time of such transfer stating the name and address of the transferee and
identifying the securities with respect to which the rights under this Section 8
are being assigned.

         9. AMENDMENTS, WAIVERS AND CONSENTS Any term, covenant agreement or
condition of this Agreement may be amended or compliance therewith may be waived
(either generally or in a particular instance and either retroactively or
prospectively), if the party against whom such amendment or waiver is to be
enforced shall consent in writing.

         10. MISCELLANEOUS

         10.1 Stamp Tax, Indemnity, Expenses The Company shall pay and save
Investor harmless against any and all liability with respect to stamp and other
taxes if any, which may be payable or which may be determined to be payable in
connection with the execution and delivery of this Agreement. Each of the
parties hereto agrees to protect and indemnify the other parties. against any
liability for any and all brokerage fees and commissions payable or claimed to
be payable to any person in connection with the issue and sale of the Securities
by the Company pursuant to this Agreement which may arise out of the actions of
such party. Except as otherwise provided in this Agreement, each party shall
bear its own expenses incurred in connection with the negotiation, execution and
performance of this Agreement.

         10.2 Notices All notices or other communications (other than those sent
to shareholders generally) provided for hereunder shall be in writing and, shall
be given by registered or certified mail (postage prepaid and return receipt
requested) or by facsimile transmission or sent by a recognized overnight
delivery service that can provide proof of delivery upon request addressed to
the Investor or the Company at their respective addresses as set forth on the
records of the company or such other address as any party may designate to the
other in accordance with the aforesaid procedure.

         10.3 Successors and Assigns. This Agreement shall be binding upon and
shall inure to the benefit of the Company and Investor and their respective
successors and assigns.

         10.4 Survival of Covenants and Representations; Indemnity All
covenants, representations and warranties made by the Company herein and in any
certificates delivered pursuant hereto, whether or not in connection with the
closing of the transactions herein contemplated, shall survive such closing and
the delivery of this Agreement. The Company shall defend, hold harmless and
indemnify the Investor from and against any and all losses, liability, claims,
actions, proceedings, expenses and costs, including without limitation
reasonable attorneys' fees and expenses (collectively, "Damages"), arising from
or relating to any breach by the Company of any representation and warranty in
Section 2 hereof, provided that:

<PAGE>   19

             (a) the Investor asserts its claim for indemnification in writing
no later than the second anniversary of the Closing Date, except such time limit
shall not apply to a claim based on a breach of a representation or warranty in
Section 2.2, 2.4, 2.18 or 2.24, all of which shall survive without time limit;

             (b) the Investor shall have incurred otherwise indemnifiable
Damages of $100,000, except that such threshold shall not apply to Damages
incurred in connection with a breach of a representation or warranty in Section
22, 2.4, 2.18 or 2.24, all of which shall be indemnifiable from the first dollar
of Damages; and

             (c) the aggregate liability of the Company to indemnify the
Investor for Damages attributable to breaches of representations and warranties
under Section 2 shall not exceed Three Million Dollars ($3,000,000) in the
aggregate.

In any litigation, arbitration or other action to enforce any of the covenants
and undertakings of the parties in this Agreement, the prevailing party shall be
entitled to recover its costs and expenses incurred in connection with such
action, including without limitation reasonable attorneys' fees and expenses,
from the non-prevailing party.

         10.5 Severability. Should any part of this Agreement for any reason be
declared invalid, such decision shall not affect the validity of any remaining
portion, which remaining portion shall remain in force and effect as if this
Agreement had been executed with the invalid portion thereof eliminated and it
is hereby declared the intention of the parties hereto that they would have
executed the remaining portion of this Agreement without including therein any
such part, parts, or portion which may, for any reason, be hereafter declared
invalid.

         10.6 Captions. The descriptive headings of the various paragraphs or
parts of this Agreement are for convenience only and shall not affect the
meaning or construction of any of the provisions hereof.

         10.7 Execution. This Agreement may be executed in one or more
counterparts, each of which shall constitute an original and all of which shall
constitute one instrument. it shall not be necessary that each party execute the
same counterpart as long as each executes at least one counterpart. Signatures
on behalf of the parties that am transmitted by facsimile machine be treated as
original and binding signatures for all purposes.

         10.8 Governing Law This Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of Colorado.

<PAGE>   20

         IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be executed by their duly authorized representatives as of the date
first written above.

                                        SPECTRUM HEALTHCARE SERVICES, INC.

                                        By:/s/ Melvin M. Mahoney
                                           -------------------------------------
                                        Melvin M. Mahoney,
                                        Vice President and Treasurer

                                        GERIMED OF AMERICA, INC.

                                        By: /s/ J. F. Riopelle
                                           -------------------------------------
                                        J.F. Riopelle,
                                        President and Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00006-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00006-of-00352.parquet"}]]